Form 4: Tenet Healthcare Director Receives Equity Grant

Director Tammy Romo was granted 1,188 restricted stock units as part of Tenet Healthcare's incentive plan.

Summary

• Director Tammy Romo received a grant of 1,188 restricted stock units (RSUs) on May 27, 2026.
• Each RSU represents the economic equivalent of one share of Tenet Healthcare common stock.
• The units are scheduled to vest on May 27, 2027, one year after the grant date.
• The reporting person has the option to receive up to 37% of the vested units in cash.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial health.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Market volatility affecting the future value of the granted equity.

Future Outlook

The restricted stock units will vest on May 27, 2027, at which point the director will receive shares or a combination of shares and cash.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practice in the healthcare sector to ensure director alignment with company performance.

Comparison to Industry Standards

• The grant follows standard industry practices for non-employee director compensation packages.
• The one-year cliff vesting schedule is consistent with typical equity incentive plans for large-cap healthcare companies.

Stakeholder Impact

• Minimal impact on shareholders as the grant represents a standard component of director compensation.

Next Steps

• Vesting of the 1,188 restricted stock units on May 27, 2027.

Key Dates

Keywords

Tenet Healthcare, THC, Form 4, Insider Trading, Equity Compensation, Director Compensation